Food and Feed Safety of NS-B5ØØ27-4 Omega-3 Canola (Brassica napus): A New Source of Long-Chain Omega-3 Fatty Acids.

DHA canola, a genetically engineered Brassica napus (OECD Unique Identifier NS-B5ØØ27-4), has been developed as one of the first land-based production systems for omega-3 long-chain polyunsaturated fatty acids (LCPUFA), whose health benefits are well-established. Yet, the marine sources of these nutrients are under high pressures due to over-fishing and increasing demand. DHA canola is a plant-based source for these essential fatty acids that produces a high level of docosahexaenoic acid (DHA). This terrestrial system allows for sustainable, scalable and stable production of omega-3 LCPUFA that addresses not only the increasing market demand, but also the complex interplay of agriculture, aquaculture, and human nutrition. The vector used to produce the desired oil profile in DHA canola contains the expression cassettes of seven genes in the DHA biosynthesis pathway and was specifically designed to convert oleic acid to DHA in canola seed. The characterization and safety evaluation of food and feed produced from DHA canola are described and supported by a detailed nutritional analysis of the seed, meal, and oil. Aside from the intended changes of the fatty acid profile, none of the other compositional analytes showed biologically meaningful differences when compared to conventional canola varieties. In addition, the meal from DHA canola is compositionally equivalent to conventional canola meal. Further evidence of nutritional value and safety of DHA canola oil have been confirmed in fish feeding studies. Given that most human populations lack sufficient daily intakes of omega-3 LCPUFA, a dietary exposure assessment is also included. In conclusion, the results from these studies demonstrate it is safe to use products derived from DHA canola in human foods, nutraceuticals, or animal feeds.

Quantitation of soybean allergens using tandem mass spectrometry.

Soybean (Glycine max) seed contain some proteins that are allergenic to humans and animals. However, the concentration of these allergens and their expression variability among germplasms is presently unknown. To address this problem, 10 allergens were quantified from 20 nongenetically modified commercial soybean varieties using parallel, label-free mass spectrometry approaches. Relative quantitation was performed by spectral counting and absolute quantitation was performed using multiple reaction monitoring (MRM) with synthetic, isotope-labeled peptides as internal standards. During relative quantitation analysis, 10 target allergens were identified, and five of these allergens showed expression levels higher than technical variation observed for bovine serum albumin (BSA) internal standard (∼11%), suggesting expression differences among the varieties. To confirm this observation, absolute quantitation of these allergens from each variety was performed using MRM. Eight of the 10 allergens were quantified for their concentration in seed and ranged from approximately 0.5 to 5.7 µg/mg of soy protein. MRM analysis reduced technical variance of BSA internal standards to approximately 7%, and confirmed differential expression for four allergens across the 20 varieties. This is the first quantitative assessment of all major soybean allergens. The results show the total quantity of allergens measured among the 20 soy varieties was mostly similar.

Managing the risk of insect resistance to transgenic insect control traits: practical approaches in local environments.

BACKGROUND: Growers have enthusiastically embraced crops genetically modified to express Bacillus thuringiensis (Bt) proteins for insect control because they provide excellent protection from key damaging insect pests around the world. Bt crops also offer superior environmental and health benefits while increasing grower income. However, insect resistance development is an important concern for all stakeholders, including growers, technology providers and seed companies that develop these genetically modified crops. Given the marked benefits associated with Bt crops, insect resistance management (IRM) must be a consideration when cultivating these crops. RESULTS: The technical data and practical experience accumulated with Bt crops in many global regions can inform different aspects of resistance management leading to robust, science-based IRM plans. A range of elements should be considered in assembling any IRM strategy, including: pest biology/ecology, product deployment patterns, local cropping systems, insect susceptibility monitoring, stakeholder/grower communications, and a remedial action plan should resistance develop. Each of these elements is described in more detail, with specific examples of how these elements can be combined and tailored to the local/regional environments and grower practices. CONCLUSION: IRM plans need to be suitable for the given production situation. What works for large monoculture production systems in North America is unlikely to be appropriate for the small, more diverse agriculture of southeast Asia or Africa. Though it is clear that Bt crops impart considerable value to growers, it is also clear that it is in the best interest of all stakeholders to preserve Bt proteins for the long-term benefits they provide.